KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Gross Profit (2016 - 2025)

Edwards Lifesciences has reported Gross Profit over the past 17 years, most recently at $1.2 billion for Q4 2025.

  • Quarterly results put Gross Profit at $1.2 billion for Q4 2025, up 12.16% from a year ago — trailing twelve months through Dec 2025 was $4.7 billion (up 9.52% YoY), and the annual figure for FY2025 was $4.7 billion, up 9.52%.
  • Gross Profit for Q4 2025 was $1.2 billion at Edwards Lifesciences, up from $1.2 billion in the prior quarter.
  • Over the last five years, Gross Profit for EW hit a ceiling of $1.2 billion in Q4 2025 and a floor of $528.7 million in Q4 2022.
  • Median Gross Profit over the past 5 years was $1.0 billion (2022), compared with a mean of $1.0 billion.
  • Biggest five-year swings in Gross Profit: tumbled 48.18% in 2022 and later surged 92.06% in 2023.
  • Edwards Lifesciences' Gross Profit stood at $1.0 billion in 2021, then crashed by 48.18% to $528.7 million in 2022, then soared by 92.06% to $1.0 billion in 2023, then rose by 7.7% to $1.1 billion in 2024, then grew by 12.16% to $1.2 billion in 2025.
  • The last three reported values for Gross Profit were $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025) per Business Quant data.